BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CANCER MORTALITY;
CYTOREDUCTIVE SURGERY;
DRUG ABSORPTION;
DRUG DISTRIBUTION;
DRUG EXPOSURE;
HUMAN;
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY;
LETTER;
MINIMAL RESIDUAL DISEASE;
NEPHROTOXICITY;
PERITONEAL CAVITY;
PERITONEUM CANCER;
Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity
Kusamura S, Baratti D, Younan R, et al. Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity. Ann Surg Oncol 2007;14:2550-8
Pharmacokinetic problems in peritoneal drug administration: Tissue penetration and surface exposure
Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst 1997;89:480-7
Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C
Sugarbaker PH, Stuart OA, Carmignani CP. Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C. Cancer Chemother Pharmacol 2006;57:703-8
Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis
Elias DM, Sideris L. Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis. Surg Oncol Clin N Am 2003;12:755-69
Extent of a parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics
de Lima Vazquez V, Stuart OA, Sugarbaker PH. Extent of a parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics. Cancer Chemother Pharmacol 2003;52:108-12
Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer
Bijelic L, Yan TD, Sugarbaker PH. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol 2007;14:2281-8
Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms
Yan TD, Bijelic L, Sugarbaker PH. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol 2007;14:2289-99